Thales Claims 'Middle Of A Crowd' Temperature Screening Testing at NHS Scotland
An 'innovative' solution that detects temperatures 'in the middle of a crowd' is being promoted by Thales, a European technology company. Indeed, Thales says NHS Scotland is testing it.
However, IPVM found significant concerns in the claims Thales made and Thales responded to IPVM, confirming that NHS Scotland is not testing 'crowd' temperature detection.
"Innovative" ***** *******
***** *********** ********* **** ******* ******* has **** **** *** ******* * decades, **** ********* ** ************ ***,** ***** *********, **** *** * ****** ********** person ******** *** *********. ******, ** contrast,********* ** '**********'******** ********* ***** ********* **** ** being ****** ** *** ********, ** Dec **, ****:
****** **** ********* ***** **** ***** a ******'* *********** ***** **** ** they *** ***** **** ****** ****** a ******** **** *** ******* ************'* temperature ***** **** ** * ***** downtilt *****:
Thales ****** *** *** ******* ** * *****
** *** ******** ** ****** ************, Thales ************ ** **** **** *** hospital ** *** ***** *** **** of ***** *******, ******:
** *** *** *********** ******, *** hospital ** ********* ** *** ***** expect ***staff *** ***** ** *** ** * ********** ******** *** ********. The camera is brought to patients where needed. [emphasis added]
****** **** **** ** ***** *** internal ******* **** *** ****** ****** walk ** *** ****** ** **** please:
** ***** ** *** ****** **** during *******, ** **** ****** **** people ******* **** ** **** ****** using ****** *********.
No ***** *** ************ **** *** ********
*** ****** ************ ********** *** ** quote ** ***** ******** **** *** Scotland ** *** *******. ****** ******* our ******* *** * ******* ****** at *** ******** *** ** *** at *** ******** *** ********* ** IPVM ***** **** *****.
Test *** ********
**** ******** ** **** *** *** test ** ***** ** ******** **** Thales ******** ** '*******[*] *** ******** of *** *******':
**** ***** ***** *** ********* **** a ****-**** ****** **** ****** *** patients — * ********** ***** ******, admittedly, *** *** ****** ** **** some *********** ************ *** ******* *** validity ** *** *******. *** ***** could *** ** ******** ** * much ******* ********** ** ********.
*******, ***** ****** ****** **** *** Scotland *** *** ** *********** ********* in * '*****', **** ****** ****** claim **** ** ********* *** ******* that **** *** ********, *.*., ***** screening.
****** **** **** **** * *** trial ** ***** *********:
** *** ********* ********** * ****** trial. *** ***** ** ********* ******* the ****** ******** *** ******* *** provide **** ** * ****** ** accuracy ** *** ****, ** ****** than, ***** *** ************, **** ** infrared ** *** ************, *** ***** consumer ******* **** ******** ************, ** a **** ***********.
Information ** *** ****** ********
****** *** ******* **** *********** ** IPVM ** ***** ********, ********** **** use ** ** ***** *****:
*** ********** **** ** ** ****** and ***** ***** *** ***** ******* and ******* ******. ** **** *** capture *** ********** ******** ** * person. *** ******* ** **** ******** people ** **** ** **** ******** by * *********** ** ********** ******** and ******** ************ ** ******* ******* and **** *********.
*******, ****** **** **** *** ***** crowd ********* ******* * *********:
***** **** ******* *** ***** **** only *** ******* *** ** * ground ***** ****** *** *** *****. The ****** ** *** ***** **** black **** ** **** ** *** temperature **********. *** ****** **** *** use *** ******* * ********* ******.
*** ****** ***** ******* **** **** they *** ***** '************ ********* *******'
**’** **** ***** ************ ********* ******* — *** **** ***** ******* ** the ********
*******, ****** ******** ** ******* **** specific ******* *** ***** **** ** specifications *** ***** *******.
Screening ** * *****
****** ************** *** ******** * *****, ***** **** ******* *** *** FDA ********* *** ******** ***** *********.*** *************** ************** **** **** *** ****** ****** be ******** ** **** *** **** this ****** ****** ** ******** *****. In * *****, ******** *** ******, will ******** **** *****, *** *** approach *** ****** **** ***** ******. In ********, **** **** ******** *****, screening ******** ****** ** *********** ******* of ***********, ***** ***** ******* ** each *******, *** ************. ****** **** IPVM **** **** ***** ****** ** many ****** ** ***** *** ****** a "********** *****" *** ******** ** specify *** ***** ** ***** ***********.
** **** ****** ** **** ****** the ***** ** **** *** ****** a ********** *****.
** *** ***** *******, ****** ****** two ******** ******** ***** ****** ***** temperatures ***** ** *** **** ****, but ** *** ******* ****** ** a *****.
Misleading ******
***** **** ****** *** ************ *** Scotland ** *** ******* '*****' *********, the ***** ******* ** **********.
** ********* *** ******** **** ******:
*** ******* ** **** ******, ********* us, *** ***** ** ** ****** because *** ******* ******** *** ******** and “** * *****”, *** **** your ********* **** *******, *** ******** is *** ******* ****** ****** ** multiple ****** ** “** * *****”. Are ** **************** ****? *** ****** clarify ****?
****** *********, ********:
**’* * ******* ***** *** ***** the ***** ****** ********* *’* ******* to, *’** **** ***** *** **** I *** ******** *****/****** **** ************ in ** *** ******, *** ***** bandwidth ** ******* ** **’** *** just ******** **** *****. **** *** in ********* ******** ** **’* ********* for ** ** *** ******* ******* your ********. **’* * ********** ***** and ** ***** ** **** **** happy ** ******* ** ****** ** due ****** **** * **** **** info. *** *’* ****** ****’* *** I *** ******* *** ** **** time. *’** **** **** ******* ** file ** * *** *** ******* updates. ****** *** **** ******** ** Thales.
****** ** * **** ****** ******* than **** ***** ******.
****** ***** ** * ****** ************* company **** ******* *** ****** ********** systems *** ******** ******** *** *** aerospace, *******, ************** *** ******** *******. The ******* ** ************* ** *****' business ********.
**,*** ********* ** ** *********.
***'* **** *** *** **** ***, on *** ***** ** **** * interaction **** ** **** *** '***** snake *** ********' ********.
**** ** ** ***** ******* **** seems ** ******* *** *** ****, mistruths & **** ****** ***................***** ** be $$$$$$$ ******?
*.*. ****** ******** ** ********** * press ******* ******* ******** *** *****?